Farmington’s Mobile Sense Technologies has been awarded a $225,000 federal grant to support a clinical trial of its wearable technology meant to detect abnormal heart rhythms called arrhythmias.
Get Instant Access to This Article
Subscribe to Hartford Business Journal and get immediate access to all of our subscriber-only content and much more.
- Critical Hartford and Connecticut business news updated daily.
- Immediate access to all subscriber-only content on our website.
- Bi-weekly print or digital editions of our award-winning publication.
- Special bonus issues like the Hartford Book of Lists.
- Exclusive ticket prize draws for our in-person events.
Click here to purchase a paywall bypass link for this article.
Farmington's Mobile Sense Technologies has been awarded a $225,000 federal grant to support a clinical trial of its wearable technology meant to detect abnormal heart rhythms called arrhythmias.
Mobile Sense said it will use the Small Business Innovation Research funding from the National Institutes of Health to run a clinical trial at the University of Massachusetts Memorial Medical Center in Worcester and to further develop its smartwatch technology to add real-time arrhythmia detection.
Arrhythmias are a leading cause of stroke and affect 120 million people worldwide, according to Mobile Sense. The company aims to use monitoring to help detect arrhythmias in people who suffer them randomly or without symptoms — and to do so without “invasive” monitors that include wires and patches.
The company's technology could help users conduct a “first-pass screen” of vital signs, before visiting a cardiologist, who could prescribe an upper-arm device for further monitoring.
Mobile Sense is headquartered at UConn Health's Technology Incubation Program, or TIP. It moved to TIP from Darien late last year.
“The platform technology developed by Mobile Sense is a key element within the emerging ehealth sector, with potential broader impact for detection and management for cardiac conditions,” said Mostafa Analoui, UConn's executive director of venture development and TIP. “The company also has balanced leadership with scientific and business expertise. This is a critical factor for its success in attracting well-deserved clinical and investment support.”
The company was co-founded by UConn professor of biomedical engineering Dr. Ki Chon, who is chief technology officer, and is led by co-founder and CEO Justin Chickles.
Mobile Sense received a $500,000 grant from Connecticut Innovations early last year.
